Navigation Links
9/11 Responders May Be At Raised Myeloma Risk
Date:8/10/2009

eloma but it's not unheard of," said Dr. Denise Pereira, assistant professor of clinical medicine at the University of Miami Miller School of Medicine. "But a lot of the things they were exposed to, such as benzene, have in the past possibly been implicated with an increased incidence in the cancer. It does make theoretical sense."

According to the Leukemia & Lymphoma Society, more than 15,000 Americans are diagnosed each year with multiple myeloma. The disease affects blood cells called B-lymphocytes. While some myelomas are slow-moving and pose little immediate threat, others can be very aggressive.

More information

There's more on health effects associated with 9/11 at the World Trade Center Registry.



SOURCES: Jacqueline M. Moline, M.D., director, World Trade Center Medical Monitoring and Treatment Program, Mount Sinai School of Medicine, New York City; Mitchell R. Smith, M.D., Ph.D., director, Lymphoma Service, Fox Chase Cancer Center, Philadelphia; Denise Pereira, M.D., assistant professor of clinical medicine, University of Miami Miller School of Medicine; August 2009 Journal of Occupational and Environmental Medicine


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

0

GOOD

Page: 1 2 3

Related medicine news :

1. September 11th First Responders Lead Emotional Rally at State Capitol Tuesday
2. Millennium Announces MLN1202 Significantly Reduced Marker of Systemic Inflammation and Identifies Genomic Biomarker For Responders
3. Emergency responders at high risk to miss work because of injuries
4. Pulmonary Fibrosis Patients/9/11 Responders Represented at State of the Union Address for Second Year in a Row
5. First Responders Acquire Revolutionary MyClyns(TM) Protective Spray
6. Iridium(R) Satellite, ProtectingAmerica.org and the American Red Cross Partner to Educate First Responders on Importance of Testing Satellite Phones
7. Specialized white blood cells coordinate first responders to viral infection
8. Lung Problems Persist for 9/11 Responders
9. University of Rochester Launches iTraining for Emergency Responders
10. Raytheon to Provide California First Responders and Healthcare Personnel Electronic Patient Tracking System
11. Kidney Awareness Time (KAT) Walk Raised Awareness and $400,000 for Kidney Education and Prevention Programs
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
9/11 Responders May Be At Raised Myeloma Risk
9/11 Responders May Be At Raised Myeloma Risk
Other Medicine Technology:Clinical Trial Data on the Safety and Efficacy of Concomitant Formoterol Fumarate/ Tiotropium Treatment for COPD 2Clinical Trial Data on the Safety and Efficacy of Concomitant Formoterol Fumarate/ Tiotropium Treatment for COPD 3Clinical Trial Data on the Safety and Efficacy of Concomitant Formoterol Fumarate/ Tiotropium Treatment for COPD 4Clinical Trial Data on the Safety and Efficacy of Concomitant Formoterol Fumarate/ Tiotropium Treatment for COPD 5Clinical Trial Data on the Safety and Efficacy of Concomitant Formoterol Fumarate/ Tiotropium Treatment for COPD 6Studies Showing Significant Survival Improvement with Taxotere(R)-based Regimens in the Induction Treatment of Patients with Locally Advanced Head and Neck Cancer are Published in the Same Issue of the New England Journal of Medicine 2Studies Showing Significant Survival Improvement with Taxotere(R)-based Regimens in the Induction Treatment of Patients with Locally Advanced Head and Neck Cancer are Published in the Same Issue of the New England Journal of Medicine 3Studies Showing Significant Survival Improvement with Taxotere(R)-based Regimens in the Induction Treatment of Patients with Locally Advanced Head and Neck Cancer are Published in the Same Issue of the New England Journal of Medicine 4Studies Showing Significant Survival Improvement with Taxotere(R)-based Regimens in the Induction Treatment of Patients with Locally Advanced Head and Neck Cancer are Published in the Same Issue of the New England Journal of Medicine 5Studies Showing Significant Survival Improvement with Taxotere(R)-based Regimens in the Induction Treatment of Patients with Locally Advanced Head and Neck Cancer are Published in the Same Issue of the New England Journal of Medicine 6Studies Showing Significant Survival Improvement with Taxotere(R)-based Regimens in the Induction Treatment of Patients with Locally Advanced Head and Neck Cancer are Published in the Same Issue of the New England Journal of Medicine 7